Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CHF Solutions Renamed Nuwellis As It Expands Beyond Heart Failure Therapy

Executive Summary

The company is expanding beyond its traditional focus on heart failure to bring its Aquadex fluid-management technology to more critical care and pediatric patients. Nuwellis’ new ticker symbol on NASDAQ is NUWE.

You may also be interested in...



Exec Chat: CHF Solutions Focused On Expanding Access To Aquadex Ultrafiltration

Nestor Jaramillo, who just finished his first quarter as CEO of CHF Solutions, told Medtech Insight how his company is making its Aquadex ultrafiltration technology part of the standard of care for heart failure patients and others with dangerous fluid overload.

Inspira Goes Public To Develop Its Alternative To Mechanical Ventilation

The Israeli company raised $16m to support its Augmented Respiration Technology, a novel approach for delivering oxygen directly into the venous system. The company expects to earn FDA clearance for first product by 2023.

Abbott’s Q2 Medical Device And Diagnostic Sales Surpass 2019 Levels

Abbott expects the ongoing recovery of medical procedure volumes to continue even as new virus variants are causing COVID-19 cases to increase in some geographies.

Topics

Related Companies

UsernamePublicRestriction

Register

MT143854

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel